Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis. Annovazzi P, Clerico M, Cocco E, Conte A, Marfia G A, Salvetti M, Tomassini V, Totaro R, Centonze D Front Neurol. 2026; 17:1829952. PMID: 42131838. Abstract CommentRecommendBookmarkWatch
